This Week in Psychedelics

Awakn Life Sciences granted fast-track for ketamine-assisted therapy for Alcohol Use Disorder; Hawaii moves toward embracing psychedelics.

February 10, 2023

This Week...

A bill to create a state working group to study the therapeutic benefits of psilocybin advanced in the Hawaii Senate with the support of the governor’s office.

SB 1454, which was introduced at the end of January by Sen. Ron Kouchi, unanimously passed the Senate Health Committee on Monday.

If enacted, the legislation would direct a new therapeutic psilocybin working group to examine the “medicinal and therapeutic effects of psilocybin to treat conditions such as post-traumatic stress disorder, depression, anxiety, and end-of-life psychological distress.” Here’s more:

Seelos Therapeutics announced that it has dosed the first patients in an ethnobridging study of healthy Japanese adults and non-Asian subjects to compare the safety and pharmacokinetic profiles of SLS-002 (intranasal racemic ketamine).

The company consulted and received endorsement from the Pharmaceuticals and Medical Devices Agency (PMDA) in Japan and from the U.S. Food and Drug Administration (FDA) to conduct this Phase I ethnobridging study. Check it out:

Awakn Life Sciences was granted fast-track designation from UK regulators for ketamine-assisted therapy for Alcohol Use Disorder. Given that alcohol use disorders affect 285 million people globally, with 70 million of these folks suffering from Severe Alcohol Use Disorder, it’s not surprising that we’re seeing increased interest in fast-tracking some of these psychedelics-based treatments, particularly since early studies have indicated exceptional results. Here’s more:

Did You Know?

Did you know that people commonly report a distinct cultural theme to the visual aspect of their psychedelic experiences?

Based on the patterns and images seen (either with eyes open or closed), people may compare them to the art and style of many ancient cultures: Egyptian, Aztec, Indian, Native American, African, and Islamic. Particular ancient cultural motifs may also characterize particular drugs – for magic mushrooms, it is the Mayan/Aztec culture, and for mescaline, it is the Native American culture. That said, such patterns can occur with other psychedelics too, such as LSD.

Here’s more: